Complementary Approaches with Free-living and Parasitic Nematodes to Understanding Anthelmintic Resistance

Trends Parasitol. 2021 Mar;37(3):240-250. doi: 10.1016/j.pt.2020.11.008. Epub 2020 Dec 13.

Abstract

Anthelmintic drugs are the major line of defense against parasitic nematode infections, but the arsenal is limited and resistance threatens sustained efficacy of the available drugs. Discoveries of the modes of action of these drugs and mechanisms of resistance have predominantly come from studies of a related nonparasitic nematode species, Caenorhabditis elegans, and the parasitic nematode Haemonchus contortus. Here, we discuss how our understanding of anthelmintic resistance and modes of action came from the interplay of results from each of these species. We argue that this 'cycle of discovery', where results from one species inform the design of experiments in the other, can use the complementary strengths of both to understand anthelmintic modes of action and mechanisms of resistance.

Keywords: C. elegans; anthelmintics; drug resistance; natural diversity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anthelmintics / pharmacology
  • Anthelmintics / therapeutic use
  • Caenorhabditis elegans / drug effects
  • Drug Resistance*
  • Haemonchus / drug effects
  • Nematoda / drug effects*
  • Nematode Infections / therapy
  • Research / standards
  • Research / trends

Substances

  • Anthelmintics